Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Indivior    INDV   GB00BRS65X63

INDIVIOR

(INDV)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Indivior PLC : annual earnings release

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/11/2019 | 09:15am EDT

The company will report its earnings for FY 2018 on 02/14/2019. Generally, the company reports earnings in line with the consensus. In recent months, the 4 analysts from Thomson Reuters consensus have revised their EPS estimates downward.

Annual earnings per share is expected at 0.35 USD for 2018 (+ 342.9% from 2017). A summary of annual publications and estimates is available below.

Annual results2015201620172018 (e)2019 (e)
Sales
Million $
Released
Forecast
Spread
1 014
1 008
0,61%
1 058
1 066
-0,76%
1 093
1 104
-1,0%

998

559
Operating income (EBITDA)
Million $
Released
Forecast
Spread
417
401
4,0%
401
410
-2,3%
416
429
-3,0%

339

31,7
Operating profit (EBIT)
Million $
Released
Forecast
Spread
377
377
-0,11%
387
368
5,0%
403
412
-2,1%

321

24,9
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
285
309
-7,6%
98,0
147
-33%
137
351
-61%

286

21,9
Net income
Million $
Released
Forecast
Spread
228
225
1,4%
35,0
60,3
-42%
58,0
260
-78%

253

32,4
EPS
 $
Released
Forecast
Spread
0,31
0,31
-0,32%
0,05
0,15
-66%
0,08
0,35
-77%

0,35

-0,03
Announcement Date02/18/201602/22/201702/15/2018
Stocks mentioned in the article
ChangeLast1st jan.
INDIVIOR -8.39% 41.58 Delayed Quote.-59.60%
THOMSON REUTERS CORPORATION -0.34% 86.85 Delayed Quote.32.19%

© MarketScreener.com 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INDIVIOR
10/16INDIVIOR : Shares in under-fire drug maker Indivior rise after top forecasts
AQ
10/15British mid-caps rise on hopes of Brexit deal this week
RE
10/01C4X DISCOVERY : British drug discovery firm C4X confident of striking deals
RE
07/31INDIVIOR : Reckitt Benckiser Group PLC - FLAT Q2. STRONGER H2 EXPECTED, FULL YEA..
AQ
07/31INDIVIOR : profit rises on slower-than-expected Suboxone market share loss
RE
07/31INDIVIOR : First Half 2019 Results Now Available; Conference Call With Leadershi..
PR
07/15LONDON STOCK EXCHANGE : Chinese data, Antofagasta help FTSE 100 end longest losi..
RE
07/15INDIVIOR : U.S. Court Finds No Patent Violation in Rivals' Generic Medicine
DJ
07/12INDIVIOR : RB reaches settlement to fully resolve all federal investigations
AQ
07/12Reckitt Benckiser Is Fined $1.4 Billion In U.S. Opioids Case -- WSJ
DJ
More news
Financials (USD)
Sales 2019 790 M
EBIT 2019 188 M
Net income 2019 153 M
Finance 2019 771 M
Yield 2019 -
P/E ratio 2019 2,57x
P/E ratio 2020 38,3x
EV / Sales2019 -0,48x
EV / Sales2020 0,19x
Capitalization 393 M
Chart INDIVIOR
Duration : Period :
Indivior Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INDIVIOR
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 0,78  $
Last Close Price 0,54  $
Spread / Highest target 54,2%
Spread / Average Target 45,6%
Spread / Lowest Target 37,6%
EPS Revisions
Managers
NameTitle
Shaun Thaxter Chief Executive Officer & Executive Director
Howard H. Pien Chairman
Mark Crossley Executive Director, Chief Operating Officer & CFO
Christian Heidbreder Chief Scientific Officer
A. Thomas McLellan Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
INDIVIOR-59.60%430
MERCK KGAA16.47%50 763
KYOWA KIRIN CO., LTD.0.30%10 058
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD31.56%9 606
JAZZ PHARMACEUTICALS PLC-1.13%6 939
BETTA PHARMACEUTICALS CO LTD--.--%3 139